Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma

O'Byrne, Kenneth J., Edwards, John G., & Waller, David A. (2004) Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma. Lung Cancer, 45(SUPPL.), S45-S48.

View at publisher


In the UK mortality from malignant mesothelioma (MM) is likely to more than double over the next 20 years and despite advances in surgery, chemotherapy and radiation treatment the overall prognosis for patients remains poor. A number of scoring systems based on assessment of clinicopathological features of patients with the disease have been developed but the search continues for further prognostic indicators. Angiogenesis, tumour necrosis (TN), epidermal growth factor receptor (EGFR) expression, cyclooxygenase-2 (COX-2) and matrix metalloproteinases (MMPs) have been linked with poor prognosis in some types of solid tumour and their relevance as prognostic factors in malignant mesothelioma is examined in this paper. © 2004 Elsevier Ireland Ltd. All rights reserved.

Impact and interest:

32 citations in Scopus
28 citations in Web of Science®
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 65283
Item Type: Journal Article
Refereed: Yes
Additional URLs:
Keywords: Angiogenesis, Cyclooxygenase (COX)-2, Epidermal growth factor receptor expression, Matrix metalloproteinases, Prognostic factor, Tumour necrosis, celecoxib, cyclooxygenase 2, epidermal growth factor receptor, matrix metalloproteinase, rofecoxib, tumor necrosis factor receptor, cancer chemotherapy, cancer mortality, cancer radiotherapy, cancer surgery, clinical trial, conference paper, human, malignant mesothelioma, priority journal, prognosis, Humans, Isoenzymes, Membrane Proteins, Mesothelioma, Neovascularization, Pathologic, Pleural Neoplasms, Prostaglandin-Endoperoxide Synthases, Receptor, Epidermal Growth Factor, Tumor Markers, Biological
DOI: 10.1016/j.lungcan.2004.04.025
ISSN: 0169-5002
Divisions: Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Copyright 2004 Elsevier Ireland Ltd
Deposited On: 11 Dec 2013 00:55
Last Modified: 07 Jan 2014 23:40

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page